Empty steel bowl beside a frosted storage box giving off vapor on a lab bench
Fat transfer vs fat banking: why one is a same-day procedure and the other is a regulated tissue bank 2

Fat transfer vs fat banking comes down to one term in FDA’s tissue rules: the same surgical procedure. A fat transfer takes fat out and puts it back into the same person in a single operation, and FDA’s rules have an exception that can cover it. Fat banking sends tissue to a lab that processes and stores it, and those steps put that lab under 21 CFR Part 1271.

TLDR A fat transfer removes fat and implants it in the same person during a single operation at one establishment, which FDA’s same surgical procedure exception generally covers. Banking sends tissue to a lab that processes and stores it, and those steps fall under 21 CFR Part 1271. Registration is not FDA approval, and banking does not guarantee any future use.

Important Disclaimer: Save My Fat does not provide FDA-approved treatments or cures for any disease. Banking adipose tissue today does not guarantee eligibility, access, or clinical benefit from any future therapy, clinical trial, or medical program. All content is for educational purposes only and does not constitute medical advice. Patients must consult their own licensed healthcare professionals regarding all medical decisions.


Start with one term: the same surgical procedure. FDA’s November 2017 guidance says it generally means tissue “removed from and implanted into the same individual within a single operation performed at the same establishment”. One person, one operation, one place.

So why does a fat transfer need no tissue bank, while banking that same fat brings in a regulated lab? The answer is where the fat goes next.

Fat Transfer vs Fat Banking: What Is the Actual Difference?

One puts the fat back into you, and the other puts it into storage. In a fat transfer, fat is taken from one part of your body and placed in another before the operation is over. In fat banking, a provider collects the tissue and sends it to a tissue bank, which processes and cryopreserves it.

The table below puts the two side by side. Each row is a question you can ask.

QuestionFat transferFat banking
Where does the fat go?Back into the same personTo a tissue bank
What is done to it?Generally only rinsing, cleansing, sizing, or shapingProcessing and cryopreservation
Which FDA rule applies?The same surgical procedure exception, if its conditions are metPart 1271

The split happens at the first row. Our banking day guide covers the patient side of a collection visit.


What Is the Same Surgical Procedure Exception?

It is one sentence in FDA’s tissue regulation. 21 CFR 1271.15(b) says: “You are not required to comply with the requirements of this part if you are an establishment that removes HCT/P’s from an individual and implants such HCT/P’s into the same individual during the same surgical procedure.”

HCT/P is FDA’s shorthand for human cells, tissues, and cellular and tissue-based products, and fat is one of them. “This part” is Part 1271, and our Part 1271 explainer covers it.

Here’s the problem. People read “not required to comply” and hear “FDA approved.” The exception excuses an establishment that fits it from Part 1271, and that is not the same as FDA approving fat transfer.


When Does a Fat Transfer Fit the Exception?

It fits when three conditions are met, and FDA spells them out in its guidance on the exception. First, the tissue goes back into the same person it came from. Second, it is implanted within the same surgical procedure. Third, the tissue remains in its original form.

Let’s talk specifics. On that third condition, the guidance says: “As a general matter, the establishment may qualify for the exception if the only processing steps taken are rinsing, cleansing, sizing, or shaping the tissue.”

FDA gives a fat example. Fat is removed, spun in a centrifuge only to remove debris and fluid, with no cell isolation, and put back into the same patient. FDA says it “generally would consider the establishment removing and implanting this HCT/P from adipose tissue to qualify for the exception”.

Notice the word “generally.” FDA does not say every fat transfer is exempt. So if someone tells you a procedure is exempt, ask how they know.


Where Does the Exception Stop?

It stops when the fat is turned into something else, or when it is headed to a different establishment.

The first limit is processing. FDA’s guidance says steps “for cell isolation, cell expansion, cell activation, or enzymatic digestion generally would not allow the HCT/P to remain ‘such HCT/P’ and the establishment would not qualify for the exception.”

FDA’s contrasting example is fat processed by enzymatic digestion or mechanical disruption to isolate stromal vascular fraction, or SVF. There, FDA says the establishment “would generally not be considered to qualify for the exception”.

The second limit is location. An establishment that removes tissue for the same person “but intends the HCT/P to be implanted at a different establishment, would not qualify for the exception.”

What about time? The only multi-day examples FDA lists inside the exception are bone flaps from a craniotomy or craniectomy, and parathyroid tissue. Fat is not on that list.


Why Does Fat Banking Put the Lab Under Part 1271?

Because processing tissue and storing tissue are both on FDA’s list of manufacturing steps. 21 CFR 1271.3(e) says manufacture “means, but is not limited to, any or all steps in the recovery, processing, storage, labeling, packaging, or distribution of any human cell or tissue”.

So a lab that processes and stores fat is doing what Part 1271 counts as manufacture, and the same surgical procedure exception does not cover it.

Then comes registration. For an HCT/P that meets the criteria in 21 CFR 1271.10, paragraph (b) tells the manufacturer: “You must register with FDA”. Whether a particular tissue meets those criteria is a separate question. Registration is not FDA approval, and our post on FDA establishment registration goes deeper.

What about the provider who collects your fat? Under 21 CFR 1271.15(f), an individual “under contract, agreement, or other arrangement with a registered establishment and engaged solely in recovering cells or tissues” and sending them there is not required to register separately. That person still “must comply with all other applicable requirements in this part”.


What Did the Ninth Circuit Decide in 2024?

It decided that a cell product made from fat did not fit the same surgical procedure exception. It did not rule on fat transfer or on tissue banking.

The ruling is a Ninth Circuit opinion filed September 27, 2024, about SVF, the enzyme-processed cell product described above. The court’s staff summary, which “constitutes no part of the opinion of the court,” says “the panel held that Defendants’ SVF constitutes a ‘drug’ under the FDCA based on the plain text of the statute.”

The opinion itself says: “Because the SVF procedure removes fat tissue but implants SVF, the procedure is not exempt from regulation under the SSP exception.” SSP is short for same surgical procedure.

The opinion reversed a district court judgment for the defendants and sent the case back. The Supreme Court docket shows the Ninth Circuit denied rehearing on December 20, 2024, and the Supreme Court denied the petition on October 14, 2025.

So it all goes back to one question: is what goes back in the same thing that came out? In that case it was not. And no adipose-derived product has FDA approval to treat any disease.


What Should You Ask Before a Fat Transfer or a Banking Visit?

Ask where your fat is going and what will be done to it. Those two answers decide which rules apply.

For a fat transfer, ask whether the fat goes back in during the same operation, at the same place it was removed. Then ask what is done to it in between.

For banking, ask who does each step. Save My Fat is a connector. A partner provider collects the tissue, and a U.S.-based tissue bank processes and cryopreserves it. Ask which establishment receives your tissue and whether it is registered with FDA. Registration is not FDA approval, but ask them to show you. Take any question about a procedure or a treatment to your own licensed provider.


Frequently Asked Questions

Is a fat transfer approved by FDA?

Not through this exception. It says an establishment that fits it is not required to comply with Part 1271, and that is not an approval.

Is every fat transfer covered by the same surgical procedure exception?

No. FDA says such procedures “generally” qualify, and only when its three conditions are met. Steps for cell isolation or enzymatic digestion generally take a procedure outside the exception.

Did the Ninth Circuit rule on fat transfer vs fat banking?

No. The 2024 opinion was about SVF, an enzyme-processed cell product made from fat. It did not rule on tissue banking, and ordinary fat transfer is not addressed in the opinion.

Can banked fat be used for a fat transfer later?

Nobody can promise that today. Tissue that was sent out and stored does not match FDA’s description of a single operation at the same establishment. Any future use depends on FDA regulatory status, physician guidance, and the availability of approved or investigational pathways at that time. Banking does not guarantee any future use.


Key Takeaways

Fat transfer vs fat banking is a question of where the fat goes. In a transfer, fat goes back into the same person in a single operation, and FDA’s same surgical procedure exception generally covers that. In banking, tissue goes to a lab that processes and stores it, which Part 1271 counts as manufacture. Neither the exception nor a registration is FDA approval. The 2024 Ninth Circuit opinion was about SVF. Banking does not guarantee any future use.

Save My Fat connects patients and providers with a U.S.-based tissue bank. It is not a tissue bank, a laboratory, a medical practice, or a treatment provider. Stem cell and regenerative medicine regulations vary by state, including specific informed-consent and disclosure requirements in Florida, Utah, California, Georgia, and Tennessee governing tissue and stem cell services. Banking adipose tissue does not connect patients to any treatment pathway, and any future use depends on FDA regulatory status, physician guidance, and the availability of approved or investigational pathways at that time.

Anyone weighing adipose tissue banking for potential future use can check the pricing page or send a question through the contact page.


Save My Fat works with a U.S.-based tissue bank for laboratory processing and storage.

This article is for educational purposes only and does not constitute medical or legal advice. Please consult your own licensed healthcare provider before making any decisions about treatment or research participation.

About the author: Oscar Tellez is the founder and CEO of Save My Fat. He holds a Bachelor of Science in Exercise Science and Health Promotion from Florida Atlantic University. He has spent a decade in the regenerative medicine industry across product distribution, laboratory and vendor relationships, and provider training. He is not a licensed clinician, and this article is educational, not medical advice.

Related guide: FDA adipose tissue regulation.